| Racial discrimination during adolescence predicts mental health deterioration in adulthood: Gender differences among Blacks S Assari, E Moazen-Zadeh, CH Caldwell, MA Zimmerman Frontiers in public health 5, 251948, 2017 | 218 | 2017 |
| Efficacy of Crocus sativus (saffron) in treatment of major depressive disorder associated with post-menopausal hot flashes: a double-blind, randomized, placebo … L Kashani, S Esalatmanesh, F Eftekhari, S Salimi, T Foroughifar, ... Archives of gynecology and obstetrics 297, 717-724, 2018 | 86 | 2018 |
| Race, depressive symptoms, and all-cause mortality in the United States S Assari, E Moazen-Zadeh, MM Lankarani, V Micol-Foster Frontiers in public health 4, 179807, 2016 | 78 | 2016 |
| Comparing duloxetine and pregabalin for treatment of pain and depression in women with fibromyalgia: an open-label randomized clinical trial A Bidari, E Moazen-Zadeh, B Ghavidel-Parsa, S Rahmani, S Hosseini, ... DARU Journal of Pharmaceutical Sciences 27 (1), 149, 2019 | 63 | 2019 |
| Ethnic variation in the cross-sectional association between domains of depressive symptoms and clinical depression S Assari, E Moazen-Zadeh Frontiers in psychiatry 7, 179299, 2016 | 52 | 2016 |
| Depressive symptoms predict major depressive disorder after 15 years among whites but not blacks E Moazen-Zadeh, S Assari Frontiers in public health 4, 174014, 2016 | 50 | 2016 |
| Effects of Saffron on Cognition, Anxiety, and Depression in Patients Undergoing Coronary Artery Bypass Grafting: A Randomized Double-Blind Placebo-Controlled Trial E Moazen-Zadeh, SH Abbasi, H Safi-Aghdam, N Shahmansouri, ... The Journal of Alternative and Complementary Medicine, 2017 | 35 | 2017 |
| Simvastatin adjunct therapy for negative symptoms of schizophrenia: a randomized double-blind placebo-controlled trial S Tajik-Esmaeeli, E Moazen-Zadeh, N Abbasi, SV Shariat, F Rezaei, ... International Clinical Psychopharmacology 32 (2), 87-94, 2017 | 34 | 2017 |
| Confirmatory Factor Analysis of the 12- Item Center for Epidemiologic Studies Depression Scale (CES-D) among Blacks and Whites S Assari, E Moazen-Zadeh Frontiers in psychiatry 7, 2016 | 32 | 2016 |
| Early intervention for people at high risk of developing bipolar disorder: a systematic review of clinical trials G Saraf, E Moazen-Zadeh, JV Pinto, K Ziafat, IJ Torres, M Kesavan, ... The Lancet Psychiatry 8 (1), 64-75, 2021 | 31 | 2021 |
| Impact of opioid agonist treatment on mental health in patients with opioid use disorder: a systematic review and network meta-analysis of randomized clinical trials E Moazen-Zadeh, K Ziafat, K Yazdani, MM Kamel, JSH Wong, ... The American journal of drug and alcohol abuse 47 (3), 280-304, 2021 | 28 | 2021 |
| Vortioxetine as adjunctive therapy to risperidone for treatment of patients with chronic schizophrenia: A randomised, double-blind, placebo-controlled clinical trial E Moazen-Zadeh, S Bayanati, K Ziafat, F Rezaei, B Mesgarpour, ... Journal of Psychopharmacology 34 (5), 506-513, 2020 | 27 | 2020 |
| Saffron (Crocus sativus) versus duloxetine for treatment of patients with fibromyalgia: A randomized double-blind clinical trial M Shakiba, E Moazen-Zadeh, AA Noorbala, M Jafarinia, P Divsalar, ... Avicenna journal of phytomedicine 8 (6), 513, 2018 | 24 | 2018 |
| Pexacerfont as a CRF1 antagonist for the treatment of withdrawal symptoms in men with heroin/methamphetamine dependence: a randomized, double-blind, placebo-controlled clinical … MJ Morabbi, E Razaghi, E Moazen-Zadeh, H Safi-Aghdam, MR Zarrindast, ... International Clinical Psychopharmacology 33 (2), 111-119, 2018 | 24 | 2018 |
| Simvastatin as an Adjunctive Therapy to Risperidone in Treatment of Autism: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial E Moazen-Zadeh, F Shirzad, MA Karkhaneh-Yousefi, R Khezri, ... Journal of Child and Adolescent Psychopharmacology, 2017 | 24 | 2017 |
| A call for action on overdose among LGBTQ people in North America E Moazen-Zadeh, M Karamouzian, H Kia, T Salway, O Ferlatte, R Knight The Lancet Psychiatry 6 (9), 725-726, 2019 | 20 | 2019 |
| Understanding eHealth cognitive behavioral therapy targeting substance use: realist review F Shams, JSH Wong, M Nikoo, A Outadi, E Moazen-Zadeh, MM Kamel, ... Journal of medical Internet research 23 (1), e20557, 2021 | 17 | 2021 |
| Comparing opium tincture and methadone for medication‐assisted treatment of patients with opioid use disorder: protocol for a multicenter parallel group noninferiority double … M Nikoo, E Moazen‐Zadeh, N Nikoo, S Javidanbardan, A Kazemi, F Choi, ... International journal of methods in psychiatric research 28 (1), e1768, 2019 | 16 | 2019 |
| Riluzole for treatment of men with methamphetamine dependence: a randomized, double-blind, placebo-controlled clinical trial MH Farahzadi, E Moazen-Zadeh, E Razaghi, MR Zarrindast, R Bidaki, ... Journal of Psychopharmacology 33 (3), 305-315, 2019 | 14 | 2019 |
| Been there, done that: lessons from Vancouver’s efforts to stem the tide of overdose deaths MR Krausz, JSH Wong, E Moazen-Zadeh, KL Jang The Canadian Journal of Psychiatry 65 (6), 377-380, 2020 | 10 | 2020 |
Shahin AkhondzadehPsychiatric Research Center, Roozbeh Hospital, Tehran University of Medical Sciences, IranVerified email at neda.net
